The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Impact of race and social deprivation on clinical outcomes in newly diagnosed multiple myeloma
In this video, Hamza Hashmi, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the findings of an ASH Research Collaborative MM Data Hub analysis assessing the impact of race and social deprivation on outcomes in patients with newly diagnosed multiple myeloma, highlighting that social deprivation, rather than race alone, is a significant predictor of inferior outcomes. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
